Compare TVRD & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TVRD | MYSE |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7M | 14.2M |
| IPO Year | 2013 | 2021 |
| Metric | TVRD | MYSE |
|---|---|---|
| Price | $1.09 | $1.02 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.88 | N/A |
| AVG Volume (30 Days) | ★ 207.0K | 20.6K |
| Earning Date | 11-13-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.01 | 56.64 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $911,000.00 | $550.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 959.30 | 26.15 |
| 52 Week Low | $0.77 | $0.99 |
| 52 Week High | $5.69 | $11.54 |
| Indicator | TVRD | MYSE |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 27.60 |
| Support Level | $0.85 | N/A |
| Resistance Level | $2.02 | $1.66 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 41.46 | 11.57 |
Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.
Myseum.AI Inc is an integrate proprietary privacy-first artificial intelligence (AI) and social media technology company. The Company is developing privacy-first agentic localized AI agents to assist in managing personal media such as photos, videos and messages, while maintaining privacy.